SEOUL — X-ray image analysis solutions created by South Korean medical artificial intelligence company Lunit will be supplied to SEHA, a UAE-based health services company, to verify the technology. After performance verification, Lunit solutions specialized in thorax and mammography can be used in various hospitals in the Middle East.
According to data published by market research firm Data Bridge Market Research, the Middle East medical imaging market is expected to reach $30.85 billion in 2029 from $20.1 billion in 2021. SEHA manages a total of 14 hospitals in Abu Dhabi.
SEHA has signed an agreement with the South Korean medical solution developer to verify the performance of an AI chest analysis solution called “Lunit INSIGHT CXR” and “Lunit INSIGHT MMG”, a specialized solution for the detection of breast cancer. breast. The Middle East hospital agency will review adoption after verification of the technology by the end of 2022.
“I hope the business agreement with SEHA will be a good opportunity to provide our products to medical institutions in the Middle East and innovate public medical services in the Middle East,” said Lunit CEO Suh Beom- seok, in a statement on October 24.
In July 2022, Cathay Life Insurance, a major life insurance company in Taiwan, signed a licensing agreement with Lunit to adopt Lunit INSIGHT CXR to examine users’ health conditions when purchasing insurance. The Taiwanese company that verifies more than 30,000 chest x-ray images for new insurance contracts each year determined lung diseases and detected unusual lesions with an accuracy rate of more than 90% using Lunit’s solution.